FRANK LITVACK, M.D.

Corporate Board Profile

Tech Score: 13/100

← Back to All Directors

Software Technology Evidence

2 mention(s) identify FRANK LITVACK, M.D. as having software/technology expertise.

Company Filing Date Evidence Reason
CAPRICOR THERAPEUTICS, INC. 2022-04-12 In 2018, he co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space. Dr. Litvack co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space, indicating experience with software-related technical skills.
CAPRICOR THERAPEUTICS, INC. 2023-04-17 In 2018, he co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space. Dr. Litvack co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space, indicating involvement in software development.

CAPRICOR THERAPEUTICS, INC.

Filing Date Source Excerpt
2009-11-02 Dr. Litvack holds an M.D. from McGill University.
2010-06-15 Dr. Litvack holds an M.D. from McGill University.
2011-04-08 Dr. Litvack holds an M.D. from McGill University.
2014-09-17 Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles.
2015-05-18 Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles.
2016-04-28 Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles.
2017-04-21 Dr. Litvack has founded and operated several healthcare ventures, both as chairman and/or chief executive officer, including Progressive Angioplasty Systems Inc., a medical device company.
2018-04-26 Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles.
2019-04-30 Dr. Litvack is a native of Canada. He completed medical school and residency at McGill University in Montreal and a Cardiovascular Fellowship at Cedars-Sinai Medical Center in Los Angeles.
2020-04-17 Dr. Litvack completed medical school and residency at McGill University and has founded and operated healthcare ventures.
2021-04-20 Dr. Litvack has founded and operated several healthcare ventures, including medical device companies, and co-founded Trialtech Medical Inc., a software and services company, but no direct programming skills are indicated.
2022-04-12 In 2018, he co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space.
2023-04-17 In 2018, he co-founded Trialtech Medical Inc., a software and services company in the clinical trial recruiting space.
2024-04-01 Dr. Litvack completed medical school and residency at McGill University and a Cardiovascular Fellowship at Cedars-Sinai Medical Center. He has founded and operated several healthcare ventures, including medical device companies.
2025-04-08 Dr. Litvack completed medical school and residency at McGill University and has been involved in medical device companies and healthcare ventures.

Data sourced from SEC filings. Last updated: 2026-02-03